Skip header and navigation

1 records – page 1 of 1.

A 10-year follow up of reproductive function in women treated for childhood cancer.

https://arctichealth.org/en/permalink/ahliterature113054
Source
Reprod Biomed Online. 2013 Aug;27(2):192-200
Publication Type
Article
Date
Aug-2013
Author
S N Nielsen
A N Andersen
K T Schmidt
C. Rechnitzer
K. Schmiegelow
J G Bentzen
E C Larsen
Author Affiliation
The Fertility Clinic, The Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Source
Reprod Biomed Online. 2013 Aug;27(2):192-200
Date
Aug-2013
Language
English
Publication Type
Article
Keywords
Abortion, Spontaneous - blood - chemically induced - etiology - pathology
Adult
Anti-Mullerian Hormone - blood
Antineoplastic Agents - adverse effects - therapeutic use
Cohort Studies
Denmark
Female
Follow-Up Studies
Humans
Infertility, Female - chemically induced - complications - etiology - pathology
Live Birth
Menstruation Disturbances - chemically induced - complications - etiology - pathology
Neoplasms - complications - drug therapy - radiotherapy
Ovary - drug effects - pathology - radiation effects
Pregnancy
Primary Ovarian Insufficiency - chemically induced - complications - etiology - pathology
Remission Induction
Risk
Survivors
Young Adult
Abstract
Previously, this study group found that female childhood cancer survivors could be at risk of early cessation of fertility. The aim of the present study was to evaluate reproductive function in the same group of survivors 10 years after the initial study. Of the original cohort of 100, 71 were re-examined. Thirty-six survivors reported regular menstrual cycles. When they were compared with 210 controls, they differed significantly in antral follicle count (AFC) (median 15 versus 18, P=0.047) but not in anti-Müllerian hormone (AMH) (median 13.0 versus 17.8 pmol/l). Survivors cured with minimal gonadotoxic treatment had significantly higher AMH and AFC compared with survivors cured with either potentially gonadotoxic treatment or treatment including alkylating chemotherapy and ovarian irradiation (20.0, 5.8 and
PubMed ID
23768622 View in PubMed
Less detail